CCM
COLL icon

Cadian Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Cadian Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,060,284
Closed -$21.6M – 29
2017
Q3 		$21.6M Sell
2,060,284
-197,817
-9% -$2.18M 1.01% 28
2017
Q2 		$28.2M Buy
2,258,101
+900,353
+66% +$8.9M 1.38% 23
2017
Q1 		$13.7M Buy
1,357,748
+438,747
+48% +$6.52M 0.65% 34
2016
Q4 		$14.3M Buy
919,001
+438,860
+91% +$7.29M 0.76% 31
2016
Q3 		$9.25M Buy
+480,141
New +$5.7M 0.49% 38

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cadian Capital Management's COLL Position: Q4 2017 in Review

Cadian Capital Management sold out of Collegium Pharmaceutical (COLL) in Q4 2017, closing a stake of 2,060,284 shares — an estimated $21.6M sold.

Cadian Capital Management first reported a position in COLL in Q3 2016 and held it in 5 quarters. The position peaked at $28.2M in Q2 2017. 101 funds tracked by Wall St. Rank hold COLL as of Q4 2017.

  • Cadian Capital Management reported no remaining Collegium Pharmaceutical position as of Q4 2017 after selling out during the quarter.
  • Cadian Capital Management sold 2,060,284 Collegium Pharmaceutical shares in Q4 2017, an estimated $21.6M.
  • Cadian Capital Management first reported a position in Collegium Pharmaceutical in Q3 2016 and held it in 5 quarters.
  • Cadian Capital Management's Collegium Pharmaceutical position peaked at $28.2M in Q2 2017.
  • 101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2017.

Based on Cadian Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.